Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

Ph not_applicable
3
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
N/ANon-phased studies
3(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Terminated1
Completed1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
0
Success Rate
50.0%
Most Advanced
N/A

Trials by Phase

N/A3 (100.0%)

Trials by Status

terminated133%
completed133%
not_yet_recruiting133%

Recent Activity

0 active trials
Showing 3 of 3
terminatednot_applicable

Correcting GUT MicrobioTa by Combined Supplementation of FibERs and BIotiN to Improve Microbiome and Optimize Bariatric Surgery Outcomes

NCT05832190
not_yet_recruitingnot_applicable

Fiber Product for Gas, Bloating, and Bowel Regularity

NCT06642766
completednot_applicable

Treatment of Constipation in Functional Dyspepsia

NCT02956187

Clinical Trials (3)

Showing 3 of 3 trials
NCT05832190Not Applicable

Correcting GUT MicrobioTa by Combined Supplementation of FibERs and BIotiN to Improve Microbiome and Optimize Bariatric Surgery Outcomes

Terminated
NCT06642766Not Applicable

Fiber Product for Gas, Bloating, and Bowel Regularity

Not Yet Recruiting
NCT02956187Not Applicable

Treatment of Constipation in Functional Dyspepsia

Completed

All 3 trials loaded

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
3